title: The treatment of acute myelogenous leukemia.
authors.affiliation: ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, England.
authors.forename: R
authors.initials: R
authors.lastname: Bassan
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: W
authors.initials: W
authors.lastname: Gregory
authors.forename: J
authors.initials: J
authors.lastname: Amess
authors.forename: R
authors.initials: R
authors.lastname: Biruls
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: T A
authors.initials: TA
authors.lastname: Lister
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D011897:Random Allocation; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D004317:Doxorubicin; D013866:Thioguanine